CD19 and diffuse large B-cell lymphoma: ALLO-501 is an anti-CD19 allogeneic CAR-T (AlloCAR TTM) with the same structure as UCART19, which has recently undergone clinical trials in the ALPHA study for the treatment of FL and R/R DLBCL.